Sonnet shareholders approve Hyperliquid merger to launch HYPE-focused crypto treasury
Key Takeaways Sonnet BioTherapeutics shareholders have approved a merger, pivoting the company to a crypto treasury strategy focused on the HYPE token. The newly combined entity, Hyperliquid Strategies Inc (HSI), will hold $888 million in assets and become one of the largest holders of HYPE. Share this article Sonnet BioTherapeutics Holdings Inc has received shareholder … Read more
https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4
Skip to content